Get started
Work

Homologous Recombination Deficiency as a Biomarker for Chemoimmunotherapy Benefit in Advanced Biliary Tract Cancer: A Multicenter Retrospective Cohort Study

Year: 2026
Type: preprint
Study design: Observational Study
DOI: 10.2139/ssrn.7323042
Authors: Oluseyi Abidoye, Heidi Kosiorek, Taro Shibuki, Angelo Pirozzi, Celine Hoyek, Abdullah Alsulaiman, Naohiro Okano, Ryne Ramaker, Cody Eslinger, Binbin Zheng-Lin, Pedro Uson, Maria Fernanda Botelho Teixeira, Daniel H. Ahn, Mohamad Bassam Sonbol, Christina Wu, Takayuki Yoshino, Mitsuho Imai, Chigusa Morizane, Hideaki Bando, Yoshiaki Nakamura, Takao Fujisawa, John H. Strickler, Mitesh Borad, Masafumi Ikeda, Tanios Bekaii-Saab
Institutions: Mayo Clinic, Kyorin University, Kyorin University Hospital, Duke University, Providence Portland Medical Center, Hospital Israelita Albert Einstein, National Cancer Center Hospital East, National Cancer Center Hospital, Duke Medical Center, Mayo Clinic Hospital
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W7204228716
Cites:
Cited by:
Related to: 10